RSS Feeds
Search

Companies

Companies

No results found for given criteria.
Please try to put more general criteria into your selection.

Related Reports

Market Research Reports provided by reports.iptechex.com
Innovations in Oncology Diagnostics
Oct 2009 - 141 pages - $3,835
FDA Withdraws Approval of Avastin in Breast Cancer
Jan 2011 - 4 pages - $500
Advancing Molecular Diagnostics to Personalize Cancer Therapy
Jun 2011 - 187 pages - $3,835
Biomarkers: A Market Briefing
Jan 2007 - 90 pages - $1,995
Advances in Drug-Diagnostic Co-Development
May 2011 - 102 pages - $3,835
The Future of In Vitro and In Vivo Diagnostic Integration
Jan 2011 - 130 pages - $3,835
Iniparib Failure: Highlights the Uncertainty in Late Stage Breast Cancer Pipeline
Mar 2011 - 5 pages - $500
Cancer, CNS & Cardiovascular Biomarkers: Players, products and prospects
Aug 2008 - 352 pages - $2,615
Avastin and the AVADO Trial Survey
Feb 2008 - $2,500
Personalized Medicine Partnering Terms and Agreements
Apr 2011 - 951 pages - $4,995
More Related Market Research Reports >>>

Your selection

Industry sector
Diagnostic del
Biomarker-based diagnostics del
Therapeutic target
Oncology del
Breast cancer del
Geographic location
Asia del
Bangladesh del

Browse By

Therapeutic target
Adenocarcinoma
Breast cancer, other
Ductal carcinoma in situ
Invasive ductal breast cancer
Invasive lobular breast cancer
Lobular carcinoma in situ
Paget's Disease

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us